Comparative analysis of risk factors for hip fracture in patients of different nationalities living in Kazakhstan

Cover Page


Cite item

Full Text

Open Access Open Access
Restricted Access Access granted
Restricted Access Subscription or Fee Access

Abstract

BACKGROUND: Osteoporosis is a multifactorial systemic skeletal disease characterized by a decrease in bone strength leading to an increased risk of fractures. Hip fracture is a serious complication of osteoporosis. It is expected in Kazakhstan by 2050 the annual number of hip fracture will increase by 140% compared to 2015 data and will amount to 28,048 cases. There are differences in the incidence of fractures and low bone mineral density in different ethnic groups. However, low bone mineral density is only one of many risk factors for osteoporotic fractures.

AIM: To study the risk factors of osteoporosis and related osteoporotic fractures in patients with hip fracture living in Kazakhstan.

MATERIALS AND METHODS: The case-control study included 98 patients with hip fracture of Kazakh (main group, n = 49) and other nationalities (control group, n = 49). In the registration card, risk factors for osteoporosis and osteoporotic fractures from the Fracture Risk Assessment (FRAX) model were distinguished, and the Find cases Assess Confirm Severity algorithm (2019) was used to diagnose sarcopenia. Statistical analysis was carried out using the Statistics 26 (IBM SPSS, США).

RESULTS: The groups were comparable in terms of gender, disability, fracture location and functional activity, surgical treatment. An increase in cases of hip fracture at an older age was found in the main group than in the control group (р = 0.035).

There were no differences in the groups for clinical risk factors for osteoporotic fractures (body weight, height, history of fractures, family history of fractures, medication, comorbidity), except for smoking (lower in Kazakhs than in the other group) (р = 0.033). Differences in 10-year probability of major osteoporotic fracture and hip fracture between groups (р = 0.34 and р = 0.74) were not found. The proportion of patients who entered the intervention threshold and at low risk did not differ in the groups (р = 0.623).

The average SARC-F (Strength, Assistance with walking, Rise from a chair, Climb stairs and Falls) score was lower among Kazakhs (р = 0.011), there is a difference between the groups when walking (р = 0.044), climbing stairs (р = 0.003). A decrease of grip strength was noted in the main group (р = 0.008), especially in men (р = 0.011), but low grip strength (р < 0.001) and signs of sarcopenia (р < 0.001) were determined only by age, not nationality.

CONCLUSIONS: The Fracture Risk Assessment (FRAX) model and intervention threshold can be applied to all residents of Kazakhstan.

Full Text

Restricted Access

About the authors

Samal M. Issayeva

Asfendiyarov Kazakh National Medical University

Author for correspondence.
Email: s.m_issayeva@mail.ru
ORCID iD: 0000-0002-0020-8464
Scopus Author ID: 57215617100
ResearcherId: AAK-5510-2020
Kazakhstan, Almaty

Olga M. Lesnyak

North-Western State Medical University named after I.I. Mechnikov

Email: olga.m.lesnyak@yandex.ru
ORCID iD: 0000-0002-0143-0614
SPIN-code: 6432-4188
Scopus Author ID: 56769681100
ResearcherId: J-5512-2013

MD, Dr. Sci. (Med.), Professor

Russian Federation, Saint Petersburg

Bakytsholpan G. Issayeva

Asfendiyarov Kazakh National Medical University

Email: sholpan_issa@mail.ru
ORCID iD: 0000-0002-4630-3985
Scopus Author ID: 57217075862

MD, Dr. Sci. (Med.), Professor

Kazakhstan, Almaty

Dina S. Dilmanova

Asfendiyarov Kazakh National Medical University

Email: dinadilmanova@mail.ru

MD, Cand. Sci. (Med.), Assistant Professor

Kazakhstan, Almaty

Meruyert A. Bissembay

Asfendiyarov Kazakh National Medical University

Email: mikonai_1994@mail.ru
ORCID iD: 0000-0003-3563-4823
Kazakhstan, Almaty

Gaukhar A. Burakhanova

Asfendiyarov Kazakh National Medical University

Email: goha.kiss@mail.ru
ORCID iD: 0000-0002-6968-5074
Kazakhstan, Almaty

References

  1. NIH Consensus Development Panel on Osteoporosis Prevention, Diagnosis, and Therapy. Osteoporosis prevention, diagnosis, and therapy. JAMA. 2001;285(6):785–795. doi: 10.1001/jama.285.6.785
  2. Johnell O, Kanis JA. An estimate of the worldwide prevalence and disability associated with osteoporotic fractures. Osteoporos Int. 2006;17(12):1726–1733. doi: 10.1007/s00198-006-0172-4
  3. Hernlund E, Svedbom A, Ivergård M, et al. Osteoporosis in the European Union: medical management, epidemiology and economic burden. Arch Osteoporos. 2013;8(1):136. doi: 10.1007/s11657-013-0136-1
  4. Borgström F, Karlsson L, Ortsäter G, et al. Fragility fractures in Europe: burden, management and opportunities. Arch Osteoporos. 2020;15(1):59. doi: 10.1007/s11657-020-0706-y
  5. Singer A, Exuzides A, Spangler L, et al. Burden of illness for osteoporotic fractures compared with other serious diseases among postmenopausal women in the United States. Mayo Clin Proc. 2015;90(1):53–62. doi: 10.1016/j.mayocp.2014.09.011
  6. Lesnyak O, Bilezikian JP, Zakroyeva A. et al. Report on the audit on burden of osteoporosis in eight countries of the Eurasian Region: Armenia, Belarus, Georgia, Moldova, Kazakhstan, the Kyrgyz Republic, the Russian Federation, and Uzbekistan. Arch Osteoporos. 2020;15(1):175. doi: 10.1007/s11657-020-00836-y
  7. Kanis JA, Odén A, McCloskey EV, et al. A systematic review of hip fracture incidence and probability of fracture worldwide. Osteoporos Int. 2012;23(9):2239–2256. doi: 10.1007/s00198-012-1964-3
  8. Issayeva S, Lesnyak O, Zakroyeva A, et al. Epidemiology of osteoporotic fracture in Kazakhstan and development of a country specific FRAX model. Arch Osteoporos. 2020;15(1):30. doi: 10.1007/s11657-020-0701-3
  9. Odén A, McCloskey EV, Kanis JA, et al. Burden of high fracture probability worldwide: secular increases 2010–2040. Osteoporos Int. 2015;26(9):2243–2248. doi: 10.1007/s00198-015-3154-6
  10. Assessment of osteoporosis at the primary health-care level. Report of a WHO Scientific Group. WHO Collaborating Centre for Metabolic Bone Diseases. University of Sheffield; 2007.
  11. Kanis JA. Assessment of fracture risk and its application to screening for postmenopausal osteoporosis: Synopsis of a WHO report. Osteoporos Int. 1994;4(6):368–381. doi: 10.1007/bf01622200
  12. Kanis JA, McCloskey EV, Johansson H, et al. A reference standard for the description of osteoporosis. Bone. 2008;42(3):467–475. doi: 10.1016/j.bone.2007.11.001
  13. Leslie WD. Ethnic differences in bone mass — clinical implications. J Clin Endocrinol Metabol. 2012;97(12):4329–4340. doi: 10.1210/jc.2012-2863
  14. Zengin A, Prentice A, Ward KA. Ethnic differences in bone health. Front Endocrinol (Lausanne). 2015;6:24. doi: 10.3389/fendo.2015.00024
  15. Shin M-H, Zmuda JM, Barrett-Connor E, et al. Race/ethnic differences in associations between bone mineral density and fracture history in older men. Osteoporos Int. 2014;25(3):837–845. doi: 10.1007/s00198-013-2503-6
  16. Turmukhametova AA. Otsenka mineralizatsii kostnoi tkani u zhitelei Kazakhstana i puti optimizatsii luchevoi diagnostiki osteoporoza [dissertation]. Astana; 2010. (In Russ.)
  17. Charlson ME, Pompei P, Ales KL, MacKenzie CR. A new method of classifying prognostic comorbidity in longitudinal studies: Development and validation. J Chronic Dis. 1987;40(5):373–383. doi: 10.1016/0021-9681(87)90171-8
  18. Lesnyak O, Zakroyeva A, Babalyan V, et al. FRAX-based intervention thresholds in eight Eurasian countries: Armenia, Belarus, Georgia, Kazakhstan, the Kyrgyz Republic, Moldova, the Russian Federation, and Uzbekistan. Arch Osteoporos. 2021;16(1):87. doi: 10.1007/s11657-021-00962-1
  19. Cruz-Jentoft AJ, Bahat G, Bauer J, et al. Sarcopenia: revised European consensus on definition and diagnosis. Age Ageing. 2019;48(4):601–601. doi: 10.1093/ageing/afz046
  20. Malmstrom TK, Morley JE. SARC-F: A Simple questionnaire to rapidly diagnose sarcopenia. J Am Med Dir Assoc. 2013;14(8):531–532. doi: 10.1016/j.jamda.2013.05.018
  21. Beaudart C, McCloskey E, Bruyère O, et al. Sarcopenia in daily practice: assessment and management. BMC Geriatr. 2016;16(1):170. doi: 10.1186/s12877-016-0349-4
  22. Lesnyak O, Ershova O, Belova K, et al. Epidemiology of fracture in the Russian Federation and the development of a FRAX model. Arch Osteoporos. 2012;7:67–73. doi: 10.1007/s11657-012-0082-3
  23. Barrett-Connor E, Siris ES, Wehren LE, et al. Osteoporosis and fracture risk in women of different ethnic groups. J Bone Miner Res. 2004;20(2):185–194. doi: 10.1359/jbmr.041007

Supplementary files

There are no supplementary files to display.


Copyright (c) 2022 Issayeva S.M., Lesnyak O.M., Issayeva B.G., Dilmanova D.S., Bissembay M.A., Burakhanova G.A.

Creative Commons License
This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.

СМИ зарегистрировано Федеральной службой по надзору в сфере связи, информационных технологий и массовых коммуникаций (Роскомнадзор).
Регистрационный номер и дата принятия решения о регистрации СМИ: серия ПИ № ФС 77 - 70763 от 21.08.2017 г.


This website uses cookies

You consent to our cookies if you continue to use our website.

About Cookies